NIH-funded research R15 grant

Understanding why BMI1 and MEL18 act differently in cells

Official title: Identifying the molecular differences between oncogenic BMI1 and its tumor suppressive paralog, MEL18

Funded at Midwestern University (Glendale Az) · NIH-11444961 · Data updated 2026-11-12

Aimed at autistic disorder, this project looks at two proteins that are very similar but have opposite effects on cell growth, to uncover clues that could lead to better treatments in the future.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionMidwestern University (Glendale Az)
NIH-funded
Lab location1 site (Glendale, United States)
Project startSeptember 17, 2026
Project endAugust 31, 2029
Funding year2026
Award (this year)$527,250
NIH project number1R15CA317831-01
Project IDNIH-11444961 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with autistic disorder who may participate in related future studies or whose samples could be used to explore epigenetic mechanisms.

Less likely to help

Direct benefit is unlikely for those not involved in related future studies or whose samples are not used in this research.

What this research studies

This project will study two closely related proteins, BMI1 and MEL18, and how they influence gene regulation in cells. By mapping the parts of each protein that change how they interact with partner molecules, researchers hope to understand why BMI1 often promotes cancer while MEL18 seems to suppress it. The work involves comparing how BMI1 and MEL18 form larger protein complexes and how these complexes affect gene expression. The findings could shed light on cellular pathways relevant to neurodevelopmental conditions like autism. The grant supports a focused, lab-based exploration that could inform future therapies tied to epigenetic regulation.

Why it matters

Potential benefit: Gains in understanding of epigenetic regulation could inform new strategies for cancer and neurodevelopmental disorders, potentially guiding future therapies.

How similar studies have gone: Prior research shows that paralogous proteins can have opposing roles, suggesting this approach could reveal meaningful differences.

Where this research is happening

  • Midwestern University (Glendale Az)
    Glendale, United States
    Active

Researchers

  • Principal investigator: Kim, Chongwoo a — Midwestern University (Glendale Az)
  • Study coordinator: Kim, Chongwoo a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.